Effectiveness of mindfulness integrated cognitive behavioral therapy on the emotional states and quality of life of patients with multiple sclerosis: A clinical trial study

authors:

avatar sabagh kermani , avatar Masoud FazilatPour , * , avatar S. M. Hossein Mousavi Nasab ORCID , avatar Hossein Ali Ebrahimi

Koomesh: Vol.22, issue 3; 446-451
published online: September 01, 2020
article type: Research Article
received: March 01, 2019
accepted: February 01, 2020

how to cite: kermani S, FazilatPour M, Mousavi Nasab S M H , Ebrahimi H A. Effectiveness of mindfulness integrated cognitive behavioral therapy on the emotional states and quality of life of patients with multiple sclerosis: A clinical trial study. koomesh. 2020;22(3):e153200. 

Abstract

Introduction: The present study was designed to investigate the effectiveness of mindfulness-integrated cognitive behaviour therapy on emotional states (depression, anxiety, & stress) and quality of life (physical health and mental health) of adults with multiple sclerosis. Materials and Methods: The studied population included all patients who referred to Kerman MS society among them 30 patients were selected using purposive sampling method and they were divided by random into the intervention group of MiCBT and a control group. Depression, Anxiety, stress scale (DASS-21) and quality of life of people with MS [MSQOL-54] questionnaire was employed as the measurement tool. Results: Results showed that physical health, mental health and quality of life, in general, was significantly increased and depression, anxiety, stress were significantly decreased in the MiCBT group when compared with the control group. Conclusion: As a result, mindfulness-integrated cognitive behaviour therapy is suggested as an effective intervention in decreasing psychological problems of people with MS, including depression, anxiety and stress and in improving their quality of life.  

References

  • 1.

    Allaane HR, Martin A S, Joshua PK. Adams & Victors principles of neurology. 10th Mac-Graw-Hill education; 2014; 916.

  • 2.

    Ebrahimi HA, Sedighi B. Prevalence of multiple sclerosis and environmental factors in Kerman province, Iran. Neurol Asia 2013; 18: 385-389.

  • 3.

    Stephan DL, Mayer A, Rowland LP. Merritts neurology. 13th edition Elan. Wolters Kluwer 2014; 594.

  • 4.

    Feinstein A. Multiple sclerosis and depression. Mult Scler 2011; 17: 1276-1281.

  • 5.

    Hart S, Fonareva I, Merluzzi Mohr DC. Treatment for depression and its relationship to improvement in quality of life and psychological well-being in multiple sclerosis patients. Qual Life Res 2005; 14: 695-703.

  • 6.

    Heidari Sorshjany S. Islami AA. Hasanzadeh A. Quality of multiple sclerosis patients in Isfahan city. Health system J 1390; 7: 580-571 (Persian).

  • 7.

    Saleh Pour GH, Rezaei S, HossienZadeh M. Quality of life in multiple sclerosis (MS) and role of fatigue, depression, anxiety, and stress: A bicenter study from north of Iran. Iran J Nurs Midwifery Res 2014; 19: 593-599.

  • 8.

    Sangalji B, Salimi Y, DastourPour M, et al. Relationship between disability and quality of life in patients with MS at Tehran MS society. Heath Dev J 1392; 2: 203-213 (Persian).

  • 9.

    Jopson NM, Moss MR. The role of illness severity and illness representation in adjusting to multiple sclerosis. J Psychosom Res 2003; 54: 503.

  • 10.

    Salami F, Zaree H, Oraki M. Predict of quality of life based on illness perception in MS patients. Uremia Med J 1392; 6: 379-392. (Persian).

  • 11.

    Cayoun B. OShea E. Mindfulness-integrated cognitive behavioural therapy: rationale for integration and the MiCBT model; 2013. Available on: mindfulness.net.au.

  • 12.

    Cayoun BA. Operationalization of mindfulness, in mindfulness-integrated CBT: principles and practice. John Wiley & Sons, Ltd: Chichester, UK; 2011.

  • 13.

    Baharani Sh, Zarghar F, Yousefipour GH, Akbari H. The effectiveness of mindfulness-integrated cognitive behavior therapy on depression, anxiety, and stress in females with multiple sclerosis: a single blind randomized controlled trial. Iran Red Crescent Med 2017; 19: 1-8.

  • 14.

    Mohr DC, Lovera J, Brown T, Cohen B, Neylan T, Henry R, et al. A randomized trial of stress management for the prevention of new brain lesions in MS. Neurology 2012; 79: 412-419.

  • 15.

    Baer RA. Mindfulness-based treatment approaches: clinician's guide to evidence base and applications. Washington: Academic Press; 2006.

  • 16.

    Delaware A. Methodology of behavioral science research, Duran Publishing: Tehran; 1391 (Persian).

  • 17.

    Vickrey B, Hays R, Harooni R, Myers L, Ellison G. A health-related quality of life measure for multiple sclerosis. Qual Life Res 1995; 4: 187-206.

  • 18.

    Lovibond PF, Lovibond SH. The structure of negative emotional states: comparison of the depression anxiety stress scales (DASS) with the beck depression and anxiety inventories. Behave Res 1995; 33: 335-343.

  • 19.

    Henry JD, Crawford JR. The short-form version of the depression anxiety stress scales (DASS-21): construct validity and normative data in a large non-clinical sample. Br J Clin Psychol 2005; 44: 227-239.

  • 20.

    Norton PT. Depression anxiety and stress scales (DASS-21): psychometric analysis across four racial groups. An Int J 2007; 20: 253-265.

  • 21.

    Dehghan A, Memarian R. Abundance of stress, anxiety and depression in multiple sclerosis patients. Alborz Univ Med J 2013; 2: 82-88. (Persian).

  • 22.

    Acquadro C, Louse L, Isabelle M. Quality of life in multiple sclerosis: translation in French Canadian of the MSQoL-54. Health Qual Life Outcomes 2003; 1: 1-7.

  • 23.

    Drulovic J, Bursac LO, Milojkovic D, Tepavcevic DK, Gazibara T, Pekmezovic T. MSQoL-54 predicts change in fatigue after inpatient rehabilitation for people with multiple sclerosis. Disabil Rehabil 2013; 35: 362-366.

  • 24.

    Pekmezovic T, Tepavcevic DK, Kostic J, Drulovic J. Validation and cross-cultural adaptation of the disease-specific questionnaire MSQOL-54 in Serbian multiple sclerosis patients sample. Qual Life Res 2007; 16: 1383-1387.

  • 25.

    Larcombe N, Wilson H. An evaluation of cognitive-behavior therapy for depression in patients with multiple sclerosis. Br J Psychiatry 1984; 1084: 366-371.

  • 26.

    Simpson R, Booth J, Lawrence M, Byrne S, Mair F, Mercer S. Mindfulness based interventions in multiple sclerosis - a systematic review. BMC Neurol 2014; 14: 1-9.

  • 27.

    Jahangirpour M, Kavand M. The effectiveness of MBCT with regard to reducing depression caused by one disorder associated with MS. special issue for the 5th psychosomatic convention. Uni Med Sci ChaharMahal Bakhtiari 2014; 29. (Persian).

  • 28.

    Roemer L, Orsillo SM. Mindfulness- and acceptance-based behavioral therapies in practice (guides to individualized evidence-based treatment). First Edit Guilford Pub 2009.

  • 29.

    Farzinrad B, Nazari KM. Comparison between effectiveness of mindfulness integrated cognitive behavioral therapy (MiCBT) and rational emotional behavior therapy (REBT) on procrastination, perfectionism and worry in students. 6th international congress on child and adolescent psychiatry. Tabriz Univ Med Sci Cong Portal 2013 (Abstract) (Persian).

  • 30.

    Baker AL, Kavanagh DJ, Kay-lambkin FJ, Hunt SA, Lewin TJ, Carr VJ, McElduff P. Randomized controlled trial of MiCBT for co-existing alcohol misuse and depression: outcomes to 36 months. J Subst Abuse Treat 2014; 46: 281-290.

  • 31.

    Sohrabi FS, Shmas-Alizadeh N. Effectiveness of mindfulness integrated cognitive-behavior therapy on depression, adherence and blood glucose control of patients with type 2 diabetes. Mellitus MiCBT Institute 2014; Available from: www.mindfulness.net.au.

  • 32.

    Yazdanimehr R, Omidi A, Sadat Z, Akbari H. The effect of mindfulness-integrated cognitive behavior therapy on depression and anxiety among pregnant women: a randomized clinical trial. J Car Sci 2016; 5: 195-204.

  • 33.

    Ghodspour Z, Najafi M, Rahimian Boogar I. Effectiveness of mindfulness-based cognitive therapy on psychological aspects of quality of life, depression, anxiety, and stress among patients with multiple sclerosis. PCP 2018; 6. (Persian).

  • 34.

    Reible DK, Greeson JM, Brainard GC, Rosenzweig S. Mindfulness-based stress reduction and health-related quality of life in a heterogeneous patient population. Gen Hosp Psychiatry 2001; 23: 183-192.

  • 35.

    Lazar SW, Kerr CE, Wasserman RH, Gray JR, Greve DN, Treadway MT, et al. Meditation experience is associated with increased cortical thickness. Neuroreport 2005; 16: 1893-1897.